Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

US-guided Pericapsular Nerve Group (PENG) Block in Different Volumes on Postoperative Pain in Hip Replacement Surgeries

NCT06166602
completednot_applicable

Postoperative Analgesic Efficacy of PENG and QLB Blocks in Hip Surgeries

NCT06653894
completednot_applicable

Evaluation of PENG Block in Terms of Block Time and Postoperative Pain

NCT06132308

Clinical Trials (3)

Showing 3 of 3 trials
NCT06166602Not Applicable

US-guided Pericapsular Nerve Group (PENG) Block in Different Volumes on Postoperative Pain in Hip Replacement Surgeries

Completed
NCT06653894Not Applicable

Postoperative Analgesic Efficacy of PENG and QLB Blocks in Hip Surgeries

Completed
NCT06132308Not Applicable

Evaluation of PENG Block in Terms of Block Time and Postoperative Pain

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3